]
Journey Colab in The Washington Post
.
Learn more
Contact Us
Menu
Our centers
Our research
Why psychedelics for addiction?
Reciprocity
Team
News
Contact Us
Latest News
View all
Journey Colab in The Washington Post
Read more
Journey Colab in Popular Science
Read more
Journey Colab in the News
April 22, 2023
Journey Colab in The Washington Post
Read article
December 7, 2022
Journey Colab in Popular Science
Read article
October 6, 2022
Journey CEO on Psychedelics as Therapy at Aspen Ideas
Read article
September 28, 2022
Journey Colab's work featured in Nature
Read article
July 25, 2022
STAT First Opinion: Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals
Read article
July 19, 2022
Journey Colab Announces Appointment of Joel A. Posener, MD as Chief Medical Officer
Read article
July 5, 2022
The Burgeoning Psychedelics Industry Is Full of Money and Good Intentions. But Can It Avoid All Of Cannabis's Mistakes?
Read article
1
...